IBDEI1FI ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25611,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,25612,0)
 ;;=796.2^^145^1544^33
 ;;^UTILITY(U,$J,358.3,25612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25612,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,25612,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,25612,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,25613,0)
 ;;=607.84^^145^1544^35
 ;;^UTILITY(U,$J,358.3,25613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25613,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,25613,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,25613,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,25614,0)
 ;;=530.81^^145^1544^36
 ;;^UTILITY(U,$J,358.3,25614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25614,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,25614,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,25614,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,25615,0)
 ;;=389.9^^145^1544^39
 ;;^UTILITY(U,$J,358.3,25615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25615,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,25615,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,25615,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,25616,0)
 ;;=784.0^^145^1544^38
 ;;^UTILITY(U,$J,358.3,25616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25616,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,25616,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,25616,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,25617,0)
 ;;=070.54^^145^1544^40
 ;;^UTILITY(U,$J,358.3,25617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25617,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,25617,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,25617,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,25618,0)
 ;;=272.4^^145^1544^41
 ;;^UTILITY(U,$J,358.3,25618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25618,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,25618,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,25618,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,25619,0)
 ;;=272.2^^145^1544^42
 ;;^UTILITY(U,$J,358.3,25619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25619,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,25619,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,25619,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,25620,0)
 ;;=401.9^^145^1544^43
 ;;^UTILITY(U,$J,358.3,25620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25620,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,25620,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,25620,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,25621,0)
 ;;=244.9^^145^1544^44
 ;;^UTILITY(U,$J,358.3,25621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25621,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,25621,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,25621,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,25622,0)
 ;;=790.21^^145^1544^45
 ;;^UTILITY(U,$J,358.3,25622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25622,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,25622,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,25622,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,25623,0)
 ;;=790.5^^145^1544^51
 ;;^UTILITY(U,$J,358.3,25623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25623,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,25623,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,25623,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,25624,0)
 ;;=724.2^^145^1544^52
 ;;^UTILITY(U,$J,358.3,25624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25624,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,25624,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,25624,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,25625,0)
 ;;=412.^^145^1544^56
 ;;^UTILITY(U,$J,358.3,25625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25625,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,25625,1,5,0)
 ;;=5^Myocardial Infarction-Old
